Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts

Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts

Bibliographic Details
Main Authors:	Guasch, Laura, Sala, Esther, Ojeda, María José, Valls, Cristina, Bladé, Cinta, Mulero, Miquel, Blay, Mayte, Ardévol, Anna, Garcia-Vallvé, Santiago, Pujadas, Gerard
Format:	Online
Language:	English
Published:	Public Library of Science 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448616/

Similar Items

Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays
by: Guasch, Laura, et al.
Published: (2012)

Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity
by: Guasch, Laura, et al.
Published: (2013)

Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs – An Ab Initio Fragment Molecular Orbital Study
by: Arulmozhiraja, Sundaram, et al.
Published: (2016)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
by: Lin, Ching-Ting, et al.
Published: (2010)

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
by: Wesley, Umadevi V., et al.
Published: (1999)

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
by: Joo, Kwon Wook, et al.
Published: (2013)

Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
by: Nojima, Hiroyuki, et al.
Published: (2016)

Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis
by: Larrinaga, Gorka, et al.
Published: (2015)

Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure
by: Salles, Thiago A., et al.
Published: (2015)

Resveratrol Enhances Palmitate-Induced ER Stress and Apoptosis in Cancer Cells
by: Rojas, Cristina, et al.
Published: (2014)

The role of bioactive compounds from Anacardium Occidentale Linn. On alpha amylase and dipeptidyl peptidase IV as antidiabetic agent for type 2 diabetes mellitus management
by: Abdullah Thaidi, Nur Imanina, et al.
Published: (2018)

Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation
by: Guasch, Laura, et al.
Published: (2012)

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?
by: Godinho, Ricardo, et al.
Published: (2015)

The good, the bad and the dubious: VHELIBS, a validation helper for ligands and binding sites
by: Cereto-Massagué, Adrià, et al.
Published: (2013)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
by: Garg, Vishvas
Published: (2011)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
by: Das, Siddhartha Shankar, et al.
Published: (2014)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Shoombuatong, Watshara, et al.
Published: (2015)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
by: Shi, Sen, et al.
Published: (2016)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Singh, Awadhesh Kumar
Published: (2014)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
by: Kim, Na-Hyung, et al.
Published: (2014)

Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis?
by: Sedo, Aleksi, et al.
Published: (2005)

Cd26/Dipeptidyl Peptidase IV in Context: The Different Roles of a Multifunctional Ectoenzyme in Malignant Transformation
by: Iwata, Satoshi, et al.
Published: (1999)

Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia
by: Röhnert, Peter, et al.
Published: (2012)

Correction: Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
by: Lim, Soo, et al.
Published: (2012)

Molecular dissection of the NH2-terminal signal/anchor sequence of rat dipeptidyl peptidase IV
Published: (1990)

Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells
Published: (1993)

Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
by: Lim, Soo, et al.
Published: (2012)

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
by: Kato, Noriyasu, et al.
Published: (2011)

Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes
by: Ikeda, Tetsurou, et al.
Published: (2013)

Dipeptidyl Peptidase IV Inhibition Activates CREB and Improves Islet Vascularization through VEGF-A/VEGFR-2 Signaling Pathway
by: Samikannu, Balaji, et al.
Published: (2013)

Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management
by: Fan, Junfeng, et al.
Published: (2013)

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model
by: Davis, Joseph A., et al.
Published: (2012)

Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
by: Al-Balas, Qosay A, et al.
Published: (2014)

Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats
by: Jin, Long, et al.
Published: (2014)

Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection
by: Zhu, Jianyong, et al.
Published: (2014)

Dipeptidyl‐peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
by: Senmaru, Takafumi, et al.
Published: (2012)

Effect of pre-treatment on the generation of dipeptidyl peptidase-IV- and prolyl endopeptidase-inhibitory hydrolysates from bovine lung
by: Lafarga T., et al.
Published: (2017-05-01)

The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes
by: Jao, Chia-Ling, et al.
Published: (2015)

Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26
by: Metzemaekers, Mieke, et al.
Published: (2016)

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
by: Suman, Rajesh Kumar, et al.
Published: (2016)